The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors
about
Serotonin promotes tumor growth in human hepatocellular cancerDepletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylationPharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptorsHead-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivoIncreased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-2155054-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytesRS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonistCharacterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissueFurther evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptorsFunctional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cellsEvidence that activation of central 5-HT(2B) receptors causes renal sympathoexcitation in anaesthetized ratsInteraction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitroThe in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's diseaseMolecular targets for therapy in systemic sclerosisStructure and function of serotonin G protein-coupled receptors.Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects.Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart diseaseRole of N-linked glycosylation of the 5-HT2A receptor in JC virus infection.5-HT radioligands for human brain imaging with PET and SPECTThe cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure.The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.Platelet-derived serotonin links vascular disease and tissue fibrosis.A review of the role of serotonin receptors in psychiatric disorders.JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.Brain serotonergic circuitriesSerotonergic activity-guided phytochemical investigation of the roots of Angelica sinensisParticipation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugsEndothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.Transmembrane signaling in the brain by serotonin, a key regulator of physiology and emotion.Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a.Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.JC virus: an oncogenic virus in animals and humans?5-HT2 receptors facilitate JC polyomavirus entry.Antagonism of serotonergic 5-HT2A/2C receptors: mutual improvement of sleep, cognition and mood?The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005-2010.Serotonin and molecular neuroimaging in humans using PET.
P2860
1aed8260f98c81545451a359f82582dd7923ad9826d1e42bce141caeb296d17411117ead0d9cd73c2763bd28b452c404d8afbfdd668430572b619da42b89556182a75b8ab480f33a33a7e51a9d1860a53d2b126e9d6901bf25a320a43d8400a9ca8ba8f23eeac97b442ca62fafcd96049f8b3cfd56a33c713f88613455663515697e243cf3cb9497d22a5b546f1d40b5147a5b795909c7a29dd6fb2b807e9bb7a8e2519a948647818d628129bd481ea651f61814f3ce059e63dcec09248addd9e0f4153ecea2646cff854075b36554589982016954784ffd2dbae33a
P248
Q24297176-2F8B4D57-ACD5-44E1-AB08-B89A51C358B9Q24309173-062217B3-1DCE-4260-9A6F-82D82EB3D720Q24321902-8FF0F94A-11DB-4B86-99DC-C946A9B31D4EQ24595389-E6CE372D-6A02-4E1B-83E8-E9C79C05F67EQ24671423-804E9D39-010A-424D-91C8-08B3284DDDEBQ24671737-D01ED3BD-CFCE-449C-B0A7-165D2BF95552Q24671935-9B784F52-259E-441F-A85A-CDA4E1AB9012Q24672108-F51482C8-9BCF-48A4-ABCA-05FC5A80337AQ24674871-AF848FCB-51F0-4B8C-98BB-00C85F3E0BE5Q24675027-B626BDFA-4135-4CD8-B2CA-C79612787B21Q24675490-585FCA34-6F33-41FA-A422-3E9E736F7625Q24680030-49FFCD2B-2C79-4972-9DFF-1130260962ADQ28142235-8B217C18-F6DA-4A1C-8E6C-C0A3999C21D8Q28253277-A32AAC81-8222-4B7B-A557-B48DF2E17436Q28290932-E56666BA-C360-475D-B38A-5198332C6C00Q28484123-BB2F17B3-F8DF-45C5-9863-858D3349E4EFQ30382524-6FCE2479-E085-4A56-B50D-89112C0F1C68Q30906677-9F96E709-F011-48CA-AB03-12B43A300851Q33213253-2EC8A3A8-4C2F-4B70-AF4D-DE7903666602Q33863285-B9AC5574-6768-49A2-822A-0A78962F4A66Q34120884-2B9C9ED8-883C-4E33-8BE5-D02E9BEAD900Q34192729-F0E236EF-7622-47DD-97E8-DF64D6308695Q34429191-A4C1E6F6-9BF7-48D2-8F55-04FA04233D85Q34546304-40FF62E1-FC3F-49E8-AB9B-2269C24DFFF8Q34728081-26238C3D-1E92-4C7E-A2B7-E63572F6E293Q34973681-67960B48-9298-41A1-97F6-C147A51F91B7Q34982486-D23C7420-5722-4D41-ACB1-D5147130A9EEQ35033782-258563BC-2A2E-4E7E-B9E4-28A20EE63F05Q35237299-A869EC9B-7A99-4A85-9E76-C0B3B722DC7AQ35785853-1C98A122-6932-4B83-8659-C3C26EC30DD6Q35873267-CC09A5C1-2B58-4DF3-ABA9-02CA4F43876AQ35884702-DFF5AB47-3525-4A7F-862E-1BA32205AA2DQ36321963-2881A19B-8DEC-4460-BA72-E707F666A09CQ36697797-1F6A2A02-7FC1-4075-9B39-CF09F70FA7B7Q36724858-374281F7-4F56-4CD9-ABBF-4111A84F798FQ37223927-029D45ED-5CC3-48A0-9BC1-197494AF4D30Q37336799-92B9397C-E0F5-4B24-BBED-176D5666D674Q37497511-FF3A2536-CE12-4A7E-998A-1038E02C89AEQ37780551-B0838B19-7CC6-495E-A9B6-CC34E280F59AQ37938794-C0A97F20-3E0F-4F2C-B134-BF7B2750C326
P2860
The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@ast
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@en
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@en-gb
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@nl
type
label
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@ast
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@en
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@en-gb
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@nl
prefLabel
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@ast
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@en
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@en-gb
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@nl
P2093
P2860
P921
P1476
The pharmacology and distribut ...... th 5-HT2A and 5-HT2C receptors
@en
P2093
B D Matsuoka
D W Bonhaus
F H Salazar
P2860
P356
10.1111/J.1476-5381.1995.TB14977.X
P407
P577
1995-06-01T00:00:00Z